Loading…
Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release
The aim of this study was to determine if the use of both enzyme and surfactant in the dissolution medium changes the in vitro drug release from cross-linked hard gelatin capsules containing a water-insoluble drug. Hard gelatin capsules were cross-linked by a controlled exposure to formaldehyde resu...
Saved in:
Published in: | European journal of pharmaceutical sciences 2003-06, Vol.19 (2), p.129-132 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c391t-4e0dce3f66b55d0a9542eee453f9186618c1b1243e38989da99b32c1d986bc4b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c391t-4e0dce3f66b55d0a9542eee453f9186618c1b1243e38989da99b32c1d986bc4b3 |
container_end_page | 132 |
container_issue | 2 |
container_start_page | 129 |
container_title | European journal of pharmaceutical sciences |
container_volume | 19 |
creator | Marchais, Hervé Cayzeele, Guillaume Legendre, Jean-Yves Skiba, Mohamed Arnaud, Philippe |
description | The aim of this study was to determine if the use of both enzyme and surfactant in the dissolution medium changes the in vitro drug release from cross-linked hard gelatin capsules containing a water-insoluble drug. Hard gelatin capsules were cross-linked by a controlled exposure to formaldehyde resulting in different stressed capsules and carbamazepine (CBZ) was chosen as a drug model. In vitro dissolution studies were conducted using simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) with enzymes. Sodium lauryl sulfate (SLS) was added in the dissolution medium at a concentration of 2% m/v both in SGF and SIF with pepsin and pancreatin, respectively. The percentage of CBZ dissolved was reduced by increasing the degree of gelatin cross-linking. For unstressed hard gelatin capsules, 36% of the CBZ was released after 1 h, lowering to 5% for highly stressed hard gelatin capsules in the SGF. A similar effect was observed with SIF. In the case of moderately stressed hard gelatin capsules, addition of enzyme in the dissolution medium enhanced the percentage of CBZ dissolved. The dissolution level increased from 12% to 39% in SGF with pepsin for hard gelatin capsules cross-linked with 1500 ppm formaldehyde. On the contrary, the use of enzyme in the dissolution medium did not increase the dissolution of CBZ from highly stressed hard gelatin capsules. Surprisingly, the addition of SLS in the medium did not allow the release of the CBZ both in SGF and in SIF. The results of this study demonstrate that the use of enzyme in the dissolution medium is justified for moderately cross-linked hard gelatin capsules. However, the action of a surfactant added in the medium containing enzyme remains unclear. |
doi_str_mv | 10.1016/S0928-0987(03)00070-8 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73368933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098703000708</els_id><sourcerecordid>73368933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-4e0dce3f66b55d0a9542eee453f9186618c1b1243e38989da99b32c1d986bc4b3</originalsourceid><addsrcrecordid>eNqF0E1PHCEYwHHS1NR124_QZi41ehgLw7yAF2M2WpuYeLA9Ewae2aLssPLMbFI_vYw70WNPQPJ7gPwJ-croGaOs_nFPZSFyKkVzQvkppbShufhAFkw0MqdNQT-SxRs5JEeIDwnVoqGfyCErGslKVi1IWMWAmHvXP7p-nYUu-6ujzdbg9eD6zOjY6o1-hq3rIZ22OHrA8wy6DswwcesQgx8HF5IOvXXTDrN0SuM7N8SQ2TiuswgeNMJnctBpj_BlXpfkz_XV79VNfnv389fq8jY3XLIhL4FaA7yr67aqLNWyKgsAKCveSSbqmgnDWlaUHLiQQlotZcsLw6wUdWvKli_J8f7ebQxPI-CgNg4NeK97CCOqhvNaSM4TrPbQTCEidGob3UbHf4pRNZVWr6XVlFFRrl5LK5Hmvs0PjO0G7PvUnDaB7zPQaLTvou6Nw3dXirIRgiV3sXeQcuwcRIXGQW_AupgaKxvcf77yAm15nB0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73368933</pqid></control><display><type>article</type><title>Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release</title><source>ScienceDirect Journals</source><creator>Marchais, Hervé ; Cayzeele, Guillaume ; Legendre, Jean-Yves ; Skiba, Mohamed ; Arnaud, Philippe</creator><creatorcontrib>Marchais, Hervé ; Cayzeele, Guillaume ; Legendre, Jean-Yves ; Skiba, Mohamed ; Arnaud, Philippe</creatorcontrib><description>The aim of this study was to determine if the use of both enzyme and surfactant in the dissolution medium changes the in vitro drug release from cross-linked hard gelatin capsules containing a water-insoluble drug. Hard gelatin capsules were cross-linked by a controlled exposure to formaldehyde resulting in different stressed capsules and carbamazepine (CBZ) was chosen as a drug model. In vitro dissolution studies were conducted using simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) with enzymes. Sodium lauryl sulfate (SLS) was added in the dissolution medium at a concentration of 2% m/v both in SGF and SIF with pepsin and pancreatin, respectively. The percentage of CBZ dissolved was reduced by increasing the degree of gelatin cross-linking. For unstressed hard gelatin capsules, 36% of the CBZ was released after 1 h, lowering to 5% for highly stressed hard gelatin capsules in the SGF. A similar effect was observed with SIF. In the case of moderately stressed hard gelatin capsules, addition of enzyme in the dissolution medium enhanced the percentage of CBZ dissolved. The dissolution level increased from 12% to 39% in SGF with pepsin for hard gelatin capsules cross-linked with 1500 ppm formaldehyde. On the contrary, the use of enzyme in the dissolution medium did not increase the dissolution of CBZ from highly stressed hard gelatin capsules. Surprisingly, the addition of SLS in the medium did not allow the release of the CBZ both in SGF and in SIF. The results of this study demonstrate that the use of enzyme in the dissolution medium is justified for moderately cross-linked hard gelatin capsules. However, the action of a surfactant added in the medium containing enzyme remains unclear.</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/S0928-0987(03)00070-8</identifier><identifier>PMID: 12791415</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Capsules ; Carbamazepine ; Carbamazepine - chemistry ; Carbamazepine - pharmacokinetics ; Cross-linking ; Cross-Linking Reagents - chemistry ; Cross-Linking Reagents - pharmacokinetics ; Dissolution with sodium lauryl sulfate ; Enzymes ; Gelatin ; General pharmacology ; Hard gelatin capsule ; Medical sciences ; Neuropharmacology ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Solubility</subject><ispartof>European journal of pharmaceutical sciences, 2003-06, Vol.19 (2), p.129-132</ispartof><rights>2003 Elsevier Science B.V.</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-4e0dce3f66b55d0a9542eee453f9186618c1b1243e38989da99b32c1d986bc4b3</citedby><cites>FETCH-LOGICAL-c391t-4e0dce3f66b55d0a9542eee453f9186618c1b1243e38989da99b32c1d986bc4b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14847881$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12791415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marchais, Hervé</creatorcontrib><creatorcontrib>Cayzeele, Guillaume</creatorcontrib><creatorcontrib>Legendre, Jean-Yves</creatorcontrib><creatorcontrib>Skiba, Mohamed</creatorcontrib><creatorcontrib>Arnaud, Philippe</creatorcontrib><title>Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>The aim of this study was to determine if the use of both enzyme and surfactant in the dissolution medium changes the in vitro drug release from cross-linked hard gelatin capsules containing a water-insoluble drug. Hard gelatin capsules were cross-linked by a controlled exposure to formaldehyde resulting in different stressed capsules and carbamazepine (CBZ) was chosen as a drug model. In vitro dissolution studies were conducted using simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) with enzymes. Sodium lauryl sulfate (SLS) was added in the dissolution medium at a concentration of 2% m/v both in SGF and SIF with pepsin and pancreatin, respectively. The percentage of CBZ dissolved was reduced by increasing the degree of gelatin cross-linking. For unstressed hard gelatin capsules, 36% of the CBZ was released after 1 h, lowering to 5% for highly stressed hard gelatin capsules in the SGF. A similar effect was observed with SIF. In the case of moderately stressed hard gelatin capsules, addition of enzyme in the dissolution medium enhanced the percentage of CBZ dissolved. The dissolution level increased from 12% to 39% in SGF with pepsin for hard gelatin capsules cross-linked with 1500 ppm formaldehyde. On the contrary, the use of enzyme in the dissolution medium did not increase the dissolution of CBZ from highly stressed hard gelatin capsules. Surprisingly, the addition of SLS in the medium did not allow the release of the CBZ both in SGF and in SIF. The results of this study demonstrate that the use of enzyme in the dissolution medium is justified for moderately cross-linked hard gelatin capsules. However, the action of a surfactant added in the medium containing enzyme remains unclear.</description><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Capsules</subject><subject>Carbamazepine</subject><subject>Carbamazepine - chemistry</subject><subject>Carbamazepine - pharmacokinetics</subject><subject>Cross-linking</subject><subject>Cross-Linking Reagents - chemistry</subject><subject>Cross-Linking Reagents - pharmacokinetics</subject><subject>Dissolution with sodium lauryl sulfate</subject><subject>Enzymes</subject><subject>Gelatin</subject><subject>General pharmacology</subject><subject>Hard gelatin capsule</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Solubility</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqF0E1PHCEYwHHS1NR124_QZi41ehgLw7yAF2M2WpuYeLA9Ewae2aLssPLMbFI_vYw70WNPQPJ7gPwJ-croGaOs_nFPZSFyKkVzQvkppbShufhAFkw0MqdNQT-SxRs5JEeIDwnVoqGfyCErGslKVi1IWMWAmHvXP7p-nYUu-6ujzdbg9eD6zOjY6o1-hq3rIZ22OHrA8wy6DswwcesQgx8HF5IOvXXTDrN0SuM7N8SQ2TiuswgeNMJnctBpj_BlXpfkz_XV79VNfnv389fq8jY3XLIhL4FaA7yr67aqLNWyKgsAKCveSSbqmgnDWlaUHLiQQlotZcsLw6wUdWvKli_J8f7ebQxPI-CgNg4NeK97CCOqhvNaSM4TrPbQTCEidGob3UbHf4pRNZVWr6XVlFFRrl5LK5Hmvs0PjO0G7PvUnDaB7zPQaLTvou6Nw3dXirIRgiV3sXeQcuwcRIXGQW_AupgaKxvcf77yAm15nB0</recordid><startdate>20030601</startdate><enddate>20030601</enddate><creator>Marchais, Hervé</creator><creator>Cayzeele, Guillaume</creator><creator>Legendre, Jean-Yves</creator><creator>Skiba, Mohamed</creator><creator>Arnaud, Philippe</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030601</creationdate><title>Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release</title><author>Marchais, Hervé ; Cayzeele, Guillaume ; Legendre, Jean-Yves ; Skiba, Mohamed ; Arnaud, Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-4e0dce3f66b55d0a9542eee453f9186618c1b1243e38989da99b32c1d986bc4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Capsules</topic><topic>Carbamazepine</topic><topic>Carbamazepine - chemistry</topic><topic>Carbamazepine - pharmacokinetics</topic><topic>Cross-linking</topic><topic>Cross-Linking Reagents - chemistry</topic><topic>Cross-Linking Reagents - pharmacokinetics</topic><topic>Dissolution with sodium lauryl sulfate</topic><topic>Enzymes</topic><topic>Gelatin</topic><topic>General pharmacology</topic><topic>Hard gelatin capsule</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Solubility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marchais, Hervé</creatorcontrib><creatorcontrib>Cayzeele, Guillaume</creatorcontrib><creatorcontrib>Legendre, Jean-Yves</creatorcontrib><creatorcontrib>Skiba, Mohamed</creatorcontrib><creatorcontrib>Arnaud, Philippe</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marchais, Hervé</au><au>Cayzeele, Guillaume</au><au>Legendre, Jean-Yves</au><au>Skiba, Mohamed</au><au>Arnaud, Philippe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2003-06-01</date><risdate>2003</risdate><volume>19</volume><issue>2</issue><spage>129</spage><epage>132</epage><pages>129-132</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>The aim of this study was to determine if the use of both enzyme and surfactant in the dissolution medium changes the in vitro drug release from cross-linked hard gelatin capsules containing a water-insoluble drug. Hard gelatin capsules were cross-linked by a controlled exposure to formaldehyde resulting in different stressed capsules and carbamazepine (CBZ) was chosen as a drug model. In vitro dissolution studies were conducted using simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) with enzymes. Sodium lauryl sulfate (SLS) was added in the dissolution medium at a concentration of 2% m/v both in SGF and SIF with pepsin and pancreatin, respectively. The percentage of CBZ dissolved was reduced by increasing the degree of gelatin cross-linking. For unstressed hard gelatin capsules, 36% of the CBZ was released after 1 h, lowering to 5% for highly stressed hard gelatin capsules in the SGF. A similar effect was observed with SIF. In the case of moderately stressed hard gelatin capsules, addition of enzyme in the dissolution medium enhanced the percentage of CBZ dissolved. The dissolution level increased from 12% to 39% in SGF with pepsin for hard gelatin capsules cross-linked with 1500 ppm formaldehyde. On the contrary, the use of enzyme in the dissolution medium did not increase the dissolution of CBZ from highly stressed hard gelatin capsules. Surprisingly, the addition of SLS in the medium did not allow the release of the CBZ both in SGF and in SIF. The results of this study demonstrate that the use of enzyme in the dissolution medium is justified for moderately cross-linked hard gelatin capsules. However, the action of a surfactant added in the medium containing enzyme remains unclear.</abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>12791415</pmid><doi>10.1016/S0928-0987(03)00070-8</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0928-0987 |
ispartof | European journal of pharmaceutical sciences, 2003-06, Vol.19 (2), p.129-132 |
issn | 0928-0987 1879-0720 |
language | eng |
recordid | cdi_proquest_miscellaneous_73368933 |
source | ScienceDirect Journals |
subjects | Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Capsules Carbamazepine Carbamazepine - chemistry Carbamazepine - pharmacokinetics Cross-linking Cross-Linking Reagents - chemistry Cross-Linking Reagents - pharmacokinetics Dissolution with sodium lauryl sulfate Enzymes Gelatin General pharmacology Hard gelatin capsule Medical sciences Neuropharmacology Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Solubility |
title | Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A23%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cross-linking%20of%20hard%20gelatin%20carbamazepine%20capsules:%20effect%20of%20dissolution%20conditions%20on%20in%20vitro%20drug%20release&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Marchais,%20Herv%C3%A9&rft.date=2003-06-01&rft.volume=19&rft.issue=2&rft.spage=129&rft.epage=132&rft.pages=129-132&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/S0928-0987(03)00070-8&rft_dat=%3Cproquest_cross%3E73368933%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c391t-4e0dce3f66b55d0a9542eee453f9186618c1b1243e38989da99b32c1d986bc4b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73368933&rft_id=info:pmid/12791415&rfr_iscdi=true |